A Drop of Blood: Newborn Heel Blood Screening Programmes, Innovations, and Contrary Voices in Türkiye and The World
Heel Blood Screening: Innovations and Oppositions
DOI:
https://doi.org/10.37609/srinmed.49Keywords:
Newborn, Heel Blood, Screening, Differences, Innovations, OppositionsAbstract
Congenital metabolic diseases are mostly autosomal recessive diseases that can be detected in the neonatal period and can lead to disability and even death if left untreated. Screening programmes for early diagnosis are organised worldwide to prevent such diseases. Heel Blood Screening (HBS), which is widely used in Türkiye and in the world, is an example of this. In our country in Türkiye, HBS is performed for phenylketonuria, biotidinase deficiency, cystic fibrosis, hypothyroidism, adrenal hyperplasia and spinal muscular atrophy. However, in recent years there has been opposition to heel prick screening among some people for different reasons. For families, navigating the abundance of available health information and making informed decisions is becoming increasingly complex. Today, when the influence of the media is stronger than ever, parents are exposed to so much information, opinions and messages about what they ‘should’ or ‘should not’ do about their children's health that it is difficult to distinguish right from wrong.
References
Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJ, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39(3):171-87.
Sağlık Bakanlığının Kuruluşunun 100. Yılında Türkiye'de Bebek Ölümleri Durum Raporu Ankara: T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü; 2021 [Available from: https://hsgm.saglik.gov.tr/depo/birimler/cocuk-ergen-sagligi-db/Dokumanlar/Kitaplar/Saglik_Bakanliginin_Kurulusunun_100._Yilinda_Turkiyede_Bebek_Olumleri_Durum_Raporu.pdf.
Akraba Evliliği ve Genetik Hastalıklar: İstinye Üniversitesi Genetik Hastalıklar Değerlendirme Merkezi; [Available from: https://isugen.com/services/akraba-evliligi-ve-genetik-hastaliklar.
Yenidoğan Topuk Kanı Taraması: T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü; [Available from: https://tektiklabilgielinde.saglik.gov.tr/bebek-sagligi/yenidogan-topuk-kani-taramasi.html.
Levy HL. Robert Guthrie and the Trials and Tribulations of Newborn Screening. Int J Neonatal Screen. 2021;7(1).
Mittal RD. Tandem mass spectroscopy in diagnosis and clinical research. Indian J Clin Biochem. 2015;30(2):121-3.
Downing M, Pollitt R. Newborn bloodspot screening in the UK--past, present and future. Ann Clin Biochem. 2008;45(Pt 1):11-7.
De Souza A, Wolan V, Battochio A, Christian S, Hume S, Johner G, et al. Newborn Screening: Current Status in Alberta, Canada. Int J Neonatal Screen. 2019;5(4):37.
Watson MS, Lloyd-Puryear MA, Howell RR. The Progress and Future of US Newborn Screening. Int J Neonatal Screen. 2022;8(3).
Bayrak R, Ünsal A. Yenidoğan Topuk Kanı Taraması İşlem Basamakları ve Görev Alan Sağlık Çalışanları. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi. 2022;5(2):60-8.
Kubaski F, Sousa I, Amorim T, Pereira D, Trometer J, Souza A, et al. Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives. Int J Neonatal Screen. 2020;6(4).
Fidan Ç, Örün H, Alper AB, Ünver Ç N, Şahin Ö C, Uğurlu Z, et al. Expanded newborn bloodspot screening: developed country examples and what can be done in Turkey. Intractable Rare Dis Res. 2022;11(2):63-9.
Newborn screening: Royal Australian College of General Practitioners; 2023 [Available from: https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/genomics-in-general-practice/genetic-tests-and-technologies/newborn-screening.
Diseases Screened: Newborn Screening Ontario; 2025 [Available from: https://www.newbornscreening.on.ca/en/screening/diseases-screened/.
Brockow I, Blankenstein O, Ceglarek U, Ensenauer R, Gramer G, Janzen N, et al. National Screening Report Germany 2018. URL: https://www screening-dgns de/Pdf/Screeningreports/DGNS-Screeningreport-e_2018 pdf. 2021.
Lund AM, Wibrand F, Skogstrand K, Bækvad-Hansen M, Gregersen N, Andresen BS, et al. Use of Molecular Genetic Analyses in Danish Routine Newborn Screening. Int J Neonatal Screen. 2021;7(3).
Newborn Screening Tests: Israel Ministry of Health; 2024 [Available from: https://me.health.gov.il/en/parenting/raising-children/after-childbirth/at-the-hospital/genetic-tests/.
Newborn blood spot test: National Health Services; 2024 [Available from: https://www.nhs.uk/baby/newborn-screening/blood-spot-test/.
Tangeraas T, Sæves I, Klingenberg C, Jørgensen J, Kristensen E, Gunnarsdottir G, et al. Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses. Int J Neonatal Screen. 2020;6(3):51.
Gosadi IM. National screening programs in Saudi Arabia: Overview, outcomes, and effectiveness. J Infect Public Health. 2019;12(5):608-14.
Ruoppolo M, Malvagia S, Boenzi S, Carducci C, Dionisi-Vici C, Teofoli F, et al. Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience. Int J Neonatal Screen. 2022;8(3).
Screened Disorders: Department of Health Wadsworth Center; [Available from: https://wadsworth.org/programs/newborn/screening/screened-disorders.
The Newborn Blood Spot Screening In The Netherlands-Monitor 2022: TNO – CHILD HEALTH; [Available from: https://www.pns.nl/sites/default/files/2024-02/HielprikMon2022-EN-def.pdf.
Meclis Araştırması Komisyonu Raporu Türkiye Büyük Millet Meclisi; Mart 2020
Hanımeli ÖA, Yılmaz Ö, Yüksel H. Primer immün yetmezlikli çocuğa yaklaşım. Dicle Tıp Dergisi. 2010;37(3):307-13.
Newborn screening: Immune Deficiency Foundation; [Available from: https://primaryimmune.org/understanding-primary-immunodeficiency/diagnosis/newborn-screening.
Mantravadi V, Bednarski JJ, Ritter MA, Gu H, Kolicheski AL, Horner C, et al. Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S. Front Immunol. 2021;12:734096.
Videbæk C, Melgaard L, Lund AM, Grønborg SW. Newborn screening for adrenoleukodystrophy: International experiences and challenges. Mol Genet Metab. 2023;140(4):107734.
Hall PL, Li H, Hagar AF, Jerris SC, Wittenauer A, Wilcox W. Newborn Screening for X-Linked Adrenoleukodystrophy in Georgia: Experiences from a Pilot Study Screening of 51,081 Newborns. Int J Neonatal Screen. 2020;6(4).
Barendsen RW, Dijkstra IME, Visser WF, Alders M, Bliek J, Boelen A, et al. Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor. Front Cell Dev Biol. 2020;8:499.
Spahiu L, Behluli E, Peterlin B, Nefic H, Hadziselimovic R, Liehr T, et al. Mucopolysaccharidosis III: Molecular basis and treatment. Pediatr Endocrinol Diabetes Metab. 2021;27(3):201-8.
Chuang CK, Lin HY, Wang TJ, Huang YH, Chan MJ, Liao HC, et al. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan. Orphanet J Rare Dis. 2018;13(1):84.
Burton BK, Charrow J, Hoganson GE, Waggoner D, Tinkle B, Braddock SR, et al. Newborn Screening for Lysosomal Storage Disorders in Illinois: The Initial 15-Month Experience. J Pediatr. 2017;190:130-5.
Wasserstein MP, Caggana M, Bailey SM, Desnick RJ, Edelmann L, Estrella L, et al. The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants. Genet Med. 2019;21(3):631-40.
Topuk kanı, kayyum atanan bebek sonrası yeniden gündemde! Rakamlar ürküttü: 5 kat arttı: TGRT Haber; 2025 [Available from: https://www.tgrthaber.com/saglik/topuk-kani-kayyum-atanan-bebek-sonrasi-yeniden-gundemde-rakamlar-urkuttu-5-kat-artti-2995915
Britto C, S PNR. Assessment of Neonatal Pain During Heel Prick: Lancet vs Needle-A Randomized Controlled Study. J Trop Pediatr. 2017;63(5):346-51.
Embong NH, Soh YC, Ming LC, Wong TW. Revisiting reflexology: Concept, evidence, current practice, and practitioner training. J Tradit Complement Med. 2015;5(4):197-206.
Topuk kanı bebeklerin ayaklarındaki "üreme noktalarından" mı alınıyor? : teyit; [Available from: https://teyit.org/analiz/topuk-kani-bebeklerin-ayaklarindaki-ureme-noktalarindan-mi-aliniyor
Bebeğinizin Sağlığı Tehlikede: Topuk Kanı: Gerçek Hayat Dergisi; [Available from: https://x.com/Gercek_Hayat/status/1682447750661656578.
Yenidoğan bebekten zorla alınan TOPUK KANI bebeğe verdiği korkunç zararlar YouTube: Emel Özuğur; [Available from: https://www.youtube.com/watch?v=hCjDtCwGZEQ.
Sezerol MA, Altaş ZM, Arslan E. The lived experience of migrant Syrian mothers' interaction with the neonatal screening program. BMC Public Health. 2025;25(1):521.
van der Pal SM, Wins S, Klapwijk JE, van Dijk T, Kater-Kuipers A, van der Ploeg CPB, et al. Parents' views on accepting, declining, and expanding newborn bloodspot screening. PLoS One. 2022;17(8):e0272585.
Etchegary H, Nicholls SG, Tessier L, Simmonds C, Potter BK, Brehaut JC, et al. Consent for newborn screening: parents' and health-care professionals' experiences of consent in practice. Eur J Hum Genet. 2016;24(11):1530-4.
Muhammed Ali Bayram Başvurusu: T.C. Anayasa Mahkemesi Kararlar Bilgi Bankası; 2016 [Available from: https://kararlarbilgibankasi.anayasa.gov.tr/BB/2014/4077.
Mahkemeden "alternatif tıp uzmanına" ithaf: Topuk kanı taraması neden önemli? : teyit; [Available from: https://teyit.org/dosya/mahkemeden-alternatif-tip-uzmanina-ithaf-topuk-kani-taramasi-neden-onemli.
Tarini BA, Goldenberg AJ. Ethical issues with newborn screening in the genomics era. Annu Rev Genomics Hum Genet. 2012;13:381-93.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Scientific Reports in Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice
Scientific Reports in Medicine is an open access scientific journal. Open access means that all content is freely available without charge to the user or his/her institution on the principle that making research freely available to the public supports a greater global exchange of knowledge. The Journal and content of this website is licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allows users to copy, distribute and transmit an article, adapt the article and make noncommercial use of the article. The CC BY-NC-ND license permits non-commercial re-use of an open access article, as long as the author is properly attributed.
Scientific Reports in Medicine requires the author as the rights holder to sign and submit the journal's agreement form prior to acceptance. The authors transfer all financial rights, especially processing, reproduction, representation, printing, distribution, and online transmittal to Academician Publishing with no limitation whatsoever, and grant Academician Publishing for its publication. This ensures both that The Journal has the right to publish the article and that the author has confirmed various things including that it is their original work and that it is based on valid research.
Authors who publish with this journal agree to the following terms:
*Authors transfer copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
*Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
*Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Self Archiving Policy
*The Journal allows authors to self-archive their articles in an open access repository. The Journal considers publishing material where a pre-print or working paper has been previously mounted online. The Journal does not consider this an exception to our policy regarding the originality of the paper (not to be published elsewhere), since the open access repository doesn't have a publisher character, but an archiving system for the benefit of the public.
The Journal's policy regarding the accepted articles requires authors not to mention, in the archived articles in an open access repository, their acceptance for publication in the journal until the article is final and no modifications can be made. Authors are not allowed to submit the paper to another publisher while is still being evaluated for the Journal or is in the process of revision after the peer review decision.
The Journal does allow the authors to archive the final published article, often a pdf file, in an open access repository, after authors inform the editorial office. The final version of the article and its internet page contains information about copyright and how to cite the article. Only this final version of the article is uploaded online, on the Journal's official website, and only this version should be used for self-archiving and should replace the previous versions uploaded by authors in the open access repository.
